Innate Pharma S.A. (IPH.PA)
-Paris 2.56 
0.04(1.54%) May 17, 11:35AM EDT
| Prev Close: | 2.56 |
|---|
| Open: | 2.60 |
|---|
| Bid: | 2.55 |
|---|
| Ask: | 2.56 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.56 - 2.60 |
|---|
| 52wk Range: | 1.38 - 3.05 |
|---|
| Volume: | 49,096 |
|---|
| Avg Vol (3m): | 179,099 |
|---|
| Market Cap: | 96.99M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 6.79 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Innate Pharma S.A., a biopharmaceutical company, engages in the development of immunotherapy drug candidates for cancer and inflammatory diseases. The company primarily develops monoclonal antibodies targeting receptors and pathways controlling th...
View More